health pharma news today obesity drugs glp-1 today A major breakthrough in the fight against is about to hit pharmacy shelves across the U.S. The FDA has just approved the world's first oral GLP -1 weight-loss medication — and it GoodRx Holdings, Inc. partners with
Description
Obes Surg 33(4):10171025 Lautenbach A et al (2022) The potential of semaglutide once-weekly in patients without type 2 diabetes with weight regain or insufficient weight loss after bariatric surgerya retrospective analysis
Kidney Week, November 1520 (2016)

Among the 12% of adults who have ever taken GLP-1 drugs, most report taking them, at least in part, to treat a chronic condition like diabetes or heart disease, with fewer saying they took them only to lose weight

Martin Whyte, Associate Professor of Metabolic Medicine, University of Surrey This article is republished from The Conversation under a Creative Commons license

70.Rx History: the Rise of GLP-1s
